About Pharmaceutical Biotechnology
Subject Code
BP605T
Semester
Semester 6
Credits
4 Credits
Pharmaceutical Biotechnology (BP605T) integrates biology, genetics, and engineering for pharmaceutical applications. It spans enzyme technology (immobilization, biosensors), genetic engineering (rDNA technology, cloning vectors, PCR), immunology (immunoglobulins, MHC, vaccines, hybridoma technology), molecular biology techniques (ELISA, blotting, microbial genetics), and industrial fermentation (production of antibiotics, vitamins, amino acids, and blood products). This subject is at the forefront of modern drug discovery and biopharmaceutical manufacturing.
Key Learning Objectives
- Enzyme Technology: Understand enzyme immobilization methods, biosensor principles, and industrial enzyme production.
- Genetic Engineering: Study rDNA technology — cloning vectors, restriction enzymes, and production of recombinant proteins (Insulin, Interferon, Vaccines).
- Immunology: Know immunoglobulin structure, MHC, hypersensitivity reactions, vaccine preparation, and hybridoma technology for monoclonal antibodies.
- Molecular Techniques: Apply ELISA, Western/Southern blotting, and understand microbial genetics (transformation, transduction, conjugation).
- Fermentation: Design and control large-scale fermentation processes for production of Penicillin, Citric acid, Vitamin B₁₂, and other biologicals.
Syllabus & Topics Covered
Unit 1: Introduction, Enzymes, Biosensors & Genetic Engineering Basics
- Brief introduction to Biotechnology with reference to Pharmaceutical Sciences.
- Enzyme Biotechnology – Methods of enzyme immobilization and applications.
- Biosensors – Working and applications in Pharmaceutical Industries.
- Brief introduction to Protein Engineering.
- Use of microbes in industry. Production of Enzymes: Amylase, Catalase, Peroxidase, Lipase, Protease, Penicillinase.
- Basic principles of genetic engineering.
Unit 2: rDNA Technology & Recombinant Products
- Study of cloning vectors, restriction endonucleases, and DNA ligase.
- Recombinant DNA technology. Application of genetic engineering in medicine.
- rDNA technology production of: Interferon, Vaccines (Hepatitis-B), Hormones (Insulin).
- Brief introduction to PCR.
Unit 3: Immunology, Vaccines & Hybridoma Technology
- Types of immunity – humoral immunity, cellular immunity.
- Structure of Immunoglobulins. Structure and Function of MHC.
- Hypersensitivity reactions, Immune stimulation, Immune suppression.
- Preparation of bacterial vaccines, toxoids, viral vaccines, antitoxins, serum-immune blood derivatives.
- Storage conditions and stability of official vaccines.
- Hybridoma technology – Production, Purification, Applications.
- Blood products and Plasma Substitutes.
Unit 4: Immunoblotting, Microbial Genetics & Biotransformation
- Immunoblotting techniques – ELISA, Western blotting, Southern blotting.
- Genetic organization of Eukaryotes and Prokaryotes.
- Microbial genetics: transformation, transduction, conjugation, plasmids, transposons.
- Introduction to Microbial biotransformation and applications.
- Mutation: Types of mutation/mutants.
Unit 5: Fermentation Technology & Blood Products
- Fermentation methods, media, equipment, sterilization, aeration, stirring.
- Large scale production fermenter design and controls.
- Production of Penicillins, Citric acid, Vitamin B₁₂, Glutamic acid, Griseofulvin.
- Blood Products: Collection, Processing, Storage of whole blood, dried plasma, plasma substitutes.
How to Score High in Pharmaceutical Biotechnology
- 1
Flowcharts for rDNA: Draw step-by-step flowcharts for recombinant Insulin, Interferon, and HBV vaccine production — these are guaranteed long-answer questions.
- 2
Immunoglobulin Diagram: A well-labeled diagram of IgG structure is essential — heavy chains, light chains, Fab, Fc, hinge region, disulfide bonds.
- 3
Compare Blotting Techniques: Make a comparison table of ELISA, Western, Southern, and Northern blotting by target, probe, and application.
- 4
Fermentation Parameters: Memorize the key parameters for each fermentation product — organism, medium, conditions, downstream processing.
Why it Matters for Career
Pharmaceutical Biotechnology opens doors to careers in the rapidly growing biopharmaceutical industry. Career paths include biotech R&D (recombinant protein development), quality control/assurance in biopharma manufacturing, clinical research with biologicals, regulatory affairs for biosimilars, fermentation technology, and immunodiagnostics.
Exam Weightage
Unit 2 (rDNA technology, recombinant products) and Unit 3 (Immunology, vaccines, hybridoma) are the most frequently examined. Unit 5 (Fermentation — Penicillin, Citric acid production) is a guaranteed long-answer. ELISA and blotting techniques from Unit 4 are common short-answer questions.
Frequently Asked Questions (FAQs)
Is Pharmaceutical Biotechnology a difficult subject?
It is moderately challenging. Unlike Pharmacokinetics (math-heavy) or Medicinal Chemistry (structure-heavy), Biotech is more conceptual and descriptive. If you understand the principles of genetic engineering and immunology, the rest follows logically. Diagrams and flowcharts are key — examiners reward well-labeled illustrations.
How is this different from Pharmaceutical Microbiology?
Pharmaceutical Microbiology (Sem 3) covers fundamental microbiology — classification, sterilization, aseptic techniques, and antimicrobial testing. Pharmaceutical Biotechnology builds on that foundation to cover APPLIED topics — genetic engineering, recombinant products, immunology, hybridoma technology, and industrial fermentation. Microbiology is the science; Biotechnology is the technology/application.
What are Biosimilars and why are they important?
Biosimilars are biological products that are highly similar to an already approved reference biologic drug. They are the biotech equivalent of generic drugs but require much more extensive testing because biological molecules are large, complex, and produced by living cells. Biosimilars cost 20-30% less than the reference biologic, improving patient access to expensive therapies like Trastuzumab (cancer), Infliximab (RA), and Insulin analogs.